Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis
NCT00523354
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Esophagitis
Interventions
DRUG:
Infliximab
Sponsor
Swiss EE Study Group